Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease.
A bacteriological study of isolates from the oral cavity of patients with Kawasaki disease (KD), age-matched non-KD patients and healthy children, showed that over half the KD and control isolates had gram-positive, catalase-negative cocci. About 50% of these organisms were identified as viridans streptococci by means of an API Strep 20 kit. Further identification by fluorometric DNA-DNA hybridisation demonstrated that the predominant species were S. oralis and S. mitis, each of which accounted for 25% of the isolates of viridans streptococci; 40% of viridans strains were unidentifiable; and S. sanguis and S. parasanguis were minor components. Studies in vivo showed that insertion of culture supernates of most of the viridans streptococci increased capillary permeability and induced redness with swelling and occasional bleeding in rabbit skin. One-third of S. mitis strains and one-fifth of the unidentified strains caused aggregation of human blood platelets, whereas S. oralis and other strains had no such effect. The distribution of extracellular lipoteichoic acids and glucan produced in the presence of sucrose was also examined. There were no significant differences in the recovery rate of viridans streptococci forming these biologically active extracellular products between KD and control groups.
Ohkuni
H
H
Division of Immunology, Nippon Medical School, Kanagawa, Japan.
Todome
Y
Y
Mizuse
M
M
Ohtani
N
N
Suzuki
H
H
Igarashi
H
H
Hashimoto
Y
Y
Ezaki
T
T
Harada
K
K
Imada
Y
Y
D000328:Adult; D000818:Animals; D001427:Bacterial Toxins / Q000096:biosynthesis / Q000633:toxicity; D002199:Capillary Permeability; D002648:Child; D002675:Child, Preschool; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D005936:Glucans / Q000096:biosynthesis / Q000633:toxicity; D006801:Humans; D007223:Infant; D008070:Lipopolysaccharides / Q000378:metabolism / Q000633:toxicity; D009080:Mucocutaneous Lymph Node Syndrome / Q000382:microbiology*; D009693:Nucleic Acid Hybridization; D010614:Pharynx / Q000382:microbiology*; D010974:Platelet Aggregation; D011817:Rabbits; D012867:Skin / Q000473:pathology; D013291:Streptococcus / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D013682:Teichoic Acids / Q000096:biosynthesis / Q000633:toxicity; D014070:Tooth / Q000382:microbiology*
D001427:Bacterial Toxins; D004269:DNA, Bacterial; D005936:Glucans; D008070:Lipopolysaccharides; D013682:Teichoic Acids; C009900:lipoteichoic acid